YMP-16696-69241 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-20
Dose 1 — Pfizer-BioNTech
2021-02-13
Dose 2 — Pfizer-BioNTech
2021-12-08
Dose 3 — Pfizer-BioNTech
2021-12-10
Registered in v-safe
2021-12-10
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain — Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Free text: Pain in my armpit

MedDRA releases: 2024-11 · check-in free text available
2021-12-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-20	Pfizer-BioNTech	No
2	2021-02-13	Pfizer-BioNTech	No
3	2021-12-08	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-10

Systemic reaction (other): Pain in my armpit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Axillary pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release